Prescription Drug Litigation Pre-emption: Following the FDA Preamble (part 1 of 2) publication | October 4, 2006
Partner Eric Lasker quoted in “Agencies Move to Override State Law As Part of Federal Rulemaking Process,” in April 6, 2006 issue of BNA’s Daily Report for Executives. publication | April 6, 2006
Dodging Daubert: Suits against drug-makers are using bad science to invent causation. publication | September 19, 2005
Superfund Law Preempts Contingent Fee Arrangements in Natural Resource Damages Suits publication | July 15, 2005
FDA Position on Federal Preemption Consistent with Law & Public Health publication | February 25, 2005
The Case Against Differential Diagnosis: Daubert, Medical Causation Testimony, and the Scientific Method publication | December 1, 2004
Daubert v. Merrell Dow Pharmaceuticals, Inc.— An Essential Tool in Natural Resource Damages Litigation publication | December 1, 2003
FDA Regulatory Action Does Not Establish Causation– FDA Borrows a Page from the Parlodel® Litigation publication | October 7, 2003
